logo
Sign In
  1. Home
  2. Search
FiltersReset Filters
8 results
  • anastrozole

    (Anastrozole Tablets)
    Medication Details
    Avet Pharmaceuticals Inc
    Usage: Anastrozole is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer, and second-line treatment for advanced breast cancer in patients with disease progression after tamoxifen therapy.
    Medication Details
    Drug Interactions
  • anastrozole

    (Anastrozole)
    Medication Details
    Chartwell RX, LLC
    Usage: Anastrozole is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced/metastatic breast cancer, and as second-line treatment for advanced breast cancer following tamoxifen therapy.
    Medication Details
    Drug Interactions
  • anastrozole

    (Anastrozole Tablets)
    Medication Details
    Yiling Pharmaceutical, Inc.
    Usage: Anastrozole is indicated for postmenopausal women with hormone receptor-positive early breast cancer as adjuvant treatment, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer. It is also used as second-line therapy after tamoxifen failure in advanced cases.
    Medication Details
    Drug Interactions
  • aromasin

    (exemestane)
    Medication Details
    Pharmacia & Upjohn Company LLC
    Usage: AROMASIN is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer after two to three years of tamoxifen therapy, and for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen.
    Medication Details
    Drug Interactions
  • exemestane

    (Exemestane)
    Medication Details
    Florida Pharmaceutical Products, LLC
    Usage: Exemestane is indicated for postmenopausal women with estrogen-receptor positive early breast cancer as adjuvant treatment after 2-3 years of tamoxifen, and for advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
    Medication Details
    Drug Interactions
  • exemestane

    (Exemestane)
    Medication Details
    Greenstone LLC
    Usage: EXEMESTANE is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer after 2-3 years of tamoxifen therapy, and for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen.
    Medication Details
    Drug Interactions
  • letrozole

    (Letrozole)
    Medication Details
    Chartwell RX, LLC
    Usage: Letrozole Tablets are indicated for the adjuvant and extended adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer, as well as for first and second-line treatment of locally advanced or metastatic breast cancer in postmenopausal women.
    Medication Details
    Drug Interactions
  • letrozole

    (Letrozole Tablets)
    Medication Details
    Yiling Pharmaceutical, Inc.
    Usage: Letrozole is indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for extended adjuvant therapy following tamoxifen. It is also used as a first and second-line treatment for advanced, locally advanced, or metastatic breast cancer in postmenopausal women.
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.